Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210314
Status:
COMPLETED
Last Update Posted:
2015-03-30
First Post:
2005-09-13
Brief Title:
Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma
Sponsor:
International Extranodal Lymphoma Study Group IELSG
Organization:
International Extranodal Lymphoma Study Group IELSG
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma B Cell |
Keywords: